|
1
|
Szentirmai E and Giannico GA: Intraductal
carcinoma of the prostate. Pathologica. 112:17–24. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xin L: Cells of origin for prostate
cancer. Adv Exp Med Biol. 1210:67–86. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sartor O and de Bono JS: Metastatic
prostate cancer. N Engl J Med. 378:645–657. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Abrams DI: An integrative approach to
prostate cancer. J Altern Complement Med. 24:872–880. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Merriel SWD, Funston G and Hamilton W:
Prostate cancer in primary care. Adv Ther. 35:1285–1294. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou CK, Check DP, Lortet-Tieulent J,
Laversanne M, Jemal A, Ferlay J, Bray F, Cook MB and Devesa SS:
Prostate cancer incidence in 43 populations worldwide: An analysis
of time trends overall and by age group. Int J Cancer.
138:1388–1400. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pang C, Guan Y, Li H, Chen W and Zhu G:
Urologic cancer in China. Jpn J Clin Oncol. 46:497–501. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shan X, Danet-Desnoyers G, Aird F, Kandela
I, Tsui R, Perfito N and Iorns E: Replication study: Androgen
receptor splice variants determine taxane sensitivity in prostate
cancer. PeerJ. 6:e46612018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kristensen LS, Andersen MS, Stagsted L,
Ebbesen KK, Hansen TB and Kjems J: The biogenesis, biology and
characterization of circular RNAs. Nat Rev Genet. 20:675–691. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen G, Wang Q, Li Z, Yang Q, Liu Y, Du Z,
Zhang G and Song Y: Circular RNA CDR1as promotes adipogenic and
suppresses osteogenic differentiation of BMSCs in steroid-induced
osteonecrosis of the femoral head. Bone. 133:1152582020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu P, Mo Y, Peng M, Tang T, Zhong Y, Deng
X, Xiong F, Guo C, Wu X, Li Y, et al: Emerging role of
tumor-related functional peptides encoded by lncRNA and circRNA.
Mol Cancer. 19:222020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Q, Wang W, Zhou Q, Chen C, Yuan W,
Liu J, Li X and Sun Z: Roles of circRNAs in the tumour
microenvironment. Mol Cancer. 19:142020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang Q and Hann SS: Biological roles and
mechanisms of circular RNA in human cancers. Onco Targets Ther.
13:2067–2092. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lei M, Zheng G, Ning Q, Zheng J and Dong
D: Translation and functional roles of circular RNAs in human
cancer. Mol Cancer. 19:302020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sheng M, Wei N, Yang HY, Yan M, Zhao QX
and Jing LJ: CircRNA UBAP2 promotes the progression of ovarian
cancer by sponging microRNA-144. Eur Rev Med Pharmacol Sci.
23:7283–7294. 2019.PubMed/NCBI
|
|
16
|
Wu Y, Zhi L, Zhao Y, Yang L and Cai F:
Knockdown of circular RNA UBAP2 inhibits the malignant behaviours
of esophageal squamous cell carcinoma by microRNA-422a/Rab10 axis.
Clin Exp Pharmacol Physiol. 47:1283–1290. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao R, Ni J, Lu S, Jiang S, You L, Liu H,
Shou J, Zhai C, Zhang W, Shao S, et al: CircUBAP2-mediated
competing endogenous RNA network modulates tumorigenesis in
pancreatic adenocarcinoma. Aging (Albany NY). 11:8484–8501. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen S, Huang V, Xu X, Livingstone J,
Soares F, Jeon J, Zeng Y, Hua JT, Petricca J, Guo H, et al:
Widespread and functional RNA circularization in localized prostate
cancer. Cell. 176:831–843. e22. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dizeyi N, Hedlund P, Bjartell A, Tinzl M,
Austild-Taskén K and Abrahamsson PA: Serotonin activates MAP kinase
and PI3K/Akt signaling pathways in prostate cancer cell lines. Urol
Oncol. 29:436–445. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pan C, Zhang L, Meng X, Qin H, Xiang Z,
Gong W, Luo W, Li D and Han X: Chronic exposure to microcystin-LR
increases the risk of prostate cancer and induces malignant
transformation of human prostate epithelial cells. Chemosphere.
263:1282952021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim J, Mizokami A, Shin M, Izumi K, Konaka
H, Kadono Y, Kitagawa Y, Keller ET, Zhang J and Namiki M: SOD3 acts
as a tumor suppressor in PC-3 prostate cancer cells via hydrogen
peroxide accumulation. Anticancer Res. 34:2821–2831.
2014.PubMed/NCBI
|
|
23
|
Wang LL and Zhang M: miR-582-5p is a
potential prognostic marker in human non-small cell lung cancer and
functions as a tumor suppressor by targeting MAP3K2. Eur Rev Med
Pharmacol Sci. 22:7760–7767. 2018.PubMed/NCBI
|
|
24
|
Chen G, Wang Q, Yang Q, Li Z, Du Z, Ren M,
Zhao H, Song Y and Zhang G: Circular RNAs hsa_circ_0032462,
hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1
expression by functioning as miRNAs sponge in human osteosarcoma.
PLoS One. 13:e02028962018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Q, Yang Q, Chen G, Du Z, Ren M, Wang
A, Zhao H, Li Z, Zhang G and Song Y: LncRNA expression profiling of
BMSCs in osteonecrosis of the femoral head associated with
increased adipogenic and decreased osteogenic differentiation. Sci
Rep. 8:91272018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dai J, Zhuang Y, Tang M, Qian Q and Chen
JP: CircRNA UBAP2 facilitates the progression of colorectal cancer
by regulating miR-199a/VEGFA pathway. Eur Rev Med Pharmacol Sci.
24:7963–7971. 2020.PubMed/NCBI
|
|
27
|
Sulaiman SA, Abdul Murad NA, Mohamad Hanif
EA, Abu N and Jamal R: Prospective advances in circular RNA
investigation. Adv Exp Med Biol. 1087:357–370. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arnaiz E, Sole C, Manterola L,
Iparraguirre L, Otaegui D and Lawrie CH: CircRNAs and cancer:
Biomarkers and master regulators. Semin Cancer Biol. 58:90–99.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Holdt LM, Kohlmaier A and Teupser D:
Circular RNAs as therapeutic agents and targets. Front Physiol.
9:12622018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hua JT, Chen S and He HH: Landscape of
noncoding RNA in prostate cancer. Trends Genet. 35:840–851. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan Z, Xiao Y, Chen Y and Luo G: Screening
and identification of epithelial-to-mesenchymal transition-related
circRNA and miRNA in prostate cancer. Pathol Res Pract.
216:1527842020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu Y, He X, Chen Y and Cao D: Long
non-coding RNA LINC00504 regulates the Warburg effect in ovarian
cancer through inhibition of miR-1244. Mol Cell Biochem. 464:39–50.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang R, Zhang Y and Li H:
miR-1244/myocyte enhancer factor 2D regulatory loop contributes to
the growth of lung carcinoma. DNA Cell Biol. 34:692–700. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lv X, Wang M, Qiang J and Guo S: Circular
RNA circ-PITX1 promotes the progression of glioblastoma by acting
as a competing endogenous RNA to regulate miR-379-5p/MAP3K2 axis.
Eur J Pharmacol. 863:1726432019. View Article : Google Scholar : PubMed/NCBI
|
